{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:25Z","timestamp":1787026825664,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Apathy strongly affects function in Alzheimer\u2019s disease and frontotemporal dementia, however its effect on function in Lewy Body Disease (LBD) has not been well-described. This study aims to (1) examine the prevalence and persistence of apathy in a large, national cohort of well-characterized patients with LBD, and (2) estimate the effect of apathy on function over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Study included 676 participants with mild cognitive impairment (MCI) or dementia in the National Alzheimer\u2019s Coordinating Center Uniform Data Set. Participants were followed for an average of 3.4\u2009\u00b1\u20091.7\u2009years and consistently had a primary diagnosis of LBD. Apathy was defined by clinician judgment, categorized into four mutually exclusive profiles: (1) never apathetic across all visits, (2) at least one but &amp;lt;50% of visits with apathy (\n                      <jats:italic>intermittent apathy<\/jats:italic>\n                      ), (3) \u226550% but not all visits with apathy (\n                      <jats:italic>persistent apathy<\/jats:italic>\n                      ), and (4)\n                      <jats:italic>always apathy<\/jats:italic>\n                      across all visits. Dementia severity was measured by baseline Clinical Dementia Rating score. Parkinsonism was defined by the presence of bradykinesia, resting tremor, rigidity, gait, and postural instability. Functional impairment was assessed using the Functional Assessment Questionnaire (FAQ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline characteristics of the sample were: average age\u2009=\u200972.9\u2009\u00b1\u20096.9, years of education\u2009=\u200915.6\u2009\u00b1\u20093.4, Mini Mental State Exam (MMSE)\u2009=\u200924.4\u2009\u00b1\u20095.4, Geriatric Depression Scale (GDS)\u2009=\u20093.8\u2009\u00b1\u20093.2, FAQ\u2009=\u200912.0\u2009\u00b1\u20099.1. 78.8% were male and 89% were non-Hispanic white. Prevalence of apathy increased from 54.4% at baseline to 65.5% in year 4. 77% of participants had apathy at some point during follow-up. Independent of cognitive status and parkinsonian features, FAQ was significantly higher in participants with intermittent\/persistent and always apathetic than never apathetic. Annual rate of decline in FAQ was faster in participants who were always apathetic than never apathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this large national longitudinal cohort of LBD patients with cognitive impairment, apathy was strongly associated with greater functional impairment at baseline and faster rate of decline over time. The magnitude of these effects were clinically important and were observed beyond the effects on function from participants\u2019 cognitive status and parkinsonism, highlighting the importance of specifically assessing for apathy in LBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2024.1339190","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T23:45:42Z","timestamp":1705535142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Apathy in Lewy body disease and its effects on functional impairment over time"],"prefix":"10.3389","volume":"15","author":[{"given":"Carolyn W.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillel T.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howie","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/00019442-200303000-00012","article-title":"Executive dysfunction and apathy predict functional impairment in Alzheimer disease","volume":"11","author":"Boyle","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jamda.2014.12.018","article-title":"The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study","volume":"16","author":"Brodaty","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11920-016-0737-7","article-title":"Apathy in dementia: systematic review of recent evidence on pharmacological treatments","volume":"18","author":"Harrison","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1111\/jgs.15343","article-title":"State of the science: apathy as a model for investigating behavioral and psychological symptoms in dementia","volume":"66","author":"Massimo","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/alz.12494","article-title":"The contribution of behavioral features to caregiver burden in FTLD spectrum disorders","volume":"18","author":"Silverman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1002\/gps.4783","article-title":"A systematic review of non-pharmacological treatments for apathy in dementia","volume":"33","author":"Theleritis","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/alz.12915","article-title":"Apathy in patients with Alzheimer's disease is a cost-driving factor","volume":"19","author":"Kruse","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000338239","article-title":"Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects","volume":"33","author":"Richard","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/alz.12358","article-title":"Diagnostic criteria for apathy in neurocognitive disorders","volume":"17","author":"Miller","year":"2021","journal-title":"Alzheimers Dement"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"ref11","year":"2019"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","article-title":"Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: a meta-analysis of longitudinal studies","volume":"50","author":"Mueller","year":"2019","journal-title":"Ageing Res Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e017504","DOI":"10.1136\/bmjopen-2017-017504","article-title":"Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study","volume":"7","author":"Price","year":"2017","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.dadm.2017.12.001","article-title":"Hospitalization in people with dementia with Lewy bodies: frequency, duration, and cost implications","volume":"10","author":"Mueller","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/WAD.0b013e318065c4a9","article-title":"Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease","volume":"21","author":"Bostrom","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-131337","article-title":"Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study","volume":"39","author":"Perri","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/gps.4933","article-title":"Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study","volume":"33","author":"Vik-Mo","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1192\/bjp.2019.195","article-title":"The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study","volume":"216","author":"Vik-Mo","year":"2020","journal-title":"Br J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/gps.1395","article-title":"Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study","volume":"20","author":"Engelborghs","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.archger.2007.07.005","article-title":"Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes","volume":"47","author":"Borroni","year":"2008","journal-title":"Arch Gerontol Geriatr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/alz.12334","article-title":"Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD)","volume":"17","author":"Galvin","year":"2021","journal-title":"Alzheimers Dement"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1017\/S0033291720002901","article-title":"Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile","volume":"52","author":"Donaghy","year":"2022","journal-title":"Psychol Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.jalz.2012.10.010","article-title":"Differences in rate of functional decline across three dementia types","volume":"9","author":"Gill","year":"2013","journal-title":"Alzheimers Dement"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/WAD.0b013e3182037edf","article-title":"Risk of decline in functional activities in dementia with Lewy bodies and Alzheimer disease","volume":"25","author":"Gill","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40120-022-00417-w","article-title":"Disease progression and longitudinal clinical outcomes of Lewy body dementia in the NACC database","volume":"12","author":"Chandler","year":"2023","journal-title":"Neurol Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jagp.2018.12.013","article-title":"Why do they just sit? Apathy as a Core symptom of Alzheimer disease","volume":"27","author":"Zhu","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e12169","DOI":"10.1002\/dad2.12169","article-title":"Prevalent, persistent, and impairing: longitudinal course and impact of apathy in Alzheimer's disease","volume":"13","author":"Grossman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","article-title":"Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer's coordinating center (NACC) database: the uniform data set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","article-title":"The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers","volume":"20","author":"Morris","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.xJIM1380[pii]","article-title":"Mild cognitive impairment \u2013 beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF03351482","article-title":"Neuropsychiatric assessment of Alzheimer's disease and related dementias","volume":"13","author":"Cummings","year":"2001","journal-title":"Aging"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J Gerontol"},{"key":"ref36","article-title":"Use of the functional activities questionnaire in older adults with dementia","volume-title":"Try this:\u00ae series. Best Practices in Nursing Care to Older Adults with dementia","author":"Mayo","year":"2016"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1533317513481092","article-title":"The validity of dependence as a health outcome measure in Alzheimer's disease","volume":"28","author":"Spackman","year":"2013","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/mdc3.12163","article-title":"Development of clinical dementia rating scale cutoff scores for patients with Parkinson's disease","volume":"2","author":"Wyman-Chick","year":"2015","journal-title":"Mov Disord Clin Pract"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/j.1532-5415.2005.53461.x","article-title":"Psychometric properties of the 15-item geriatric depression scale in functionally impaired, cognitively intact, community-dwelling elderly primary care patients","volume":"53","author":"Friedman","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"ref41","volume-title":"Stata statistical software: Release 17","year":"2021"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e2245656","DOI":"10.1001\/jamanetworkopen.2022.45656","article-title":"Apathy and functional impairment in the course of behavioral variant frontotemporal dementia","volume":"5","author":"Zhu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","article-title":"Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials","volume":"5","author":"Andrews","year":"2019","journal-title":"Alzheimers Dement"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/ijerph182010707","article-title":"Predictors of caregiver burden of patients with Alzheimer disease attending day-care Centres","volume":"18","author":"Gomez-Gallego","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12877-021-02007-1","article-title":"Predictors of caregiver burden in aged caregivers of demented older patients","volume":"21","author":"Tsai","year":"2021","journal-title":"BMC Geriatr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/brainsci13071061","article-title":"A systematic review of pharmacological interventions for apathy in aging neurocognitive disorders","volume":"13","author":"Theleritis","year":"2023","journal-title":"Brain Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1017\/S1041610217002010","article-title":"Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia","volume":"30","author":"Morrin","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40263-021-00883-0","article-title":"Pharmacological Management of Apathy in dementia","volume":"36","author":"Azhar","year":"2022","journal-title":"CNS Drugs"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1339190\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T23:45:45Z","timestamp":1705535145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1339190\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":49,"alternative-id":["10.3389\/fneur.2024.1339190"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1339190","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"article-number":"1339190"}}